Mechanisms of Lung Injury and Bronchopulmonary Dysplasia

Alan H Jobe1

  • 1Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Insights

Bronchopulmonary dysplasia (BPD) affects premature infants, with significant knowledge gaps in its causes and treatments. Early steroid use shows promise in reducing BPD incidence and severity.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Developmental Biology

Background:

  • Bronchopulmonary dysplasia (BPD) is a common complication in infants born before 30 weeks gestational age.
  • Current understanding of BPD pathophysiology and effective targeted therapies remains limited.
  • BPD incidence correlates with decreased gestational age, low birth weight, growth restriction, male sex, fetal exposures, and postnatal respiratory care.

Purpose of the Study:

  • To review the significant challenges and knowledge gaps in understanding lung injury and BPD for clinicians and researchers.
  • To highlight the need for improved definitions and predictive tools for BPD outcomes.
  • To explore the complex interplay of prenatal and postnatal factors contributing to BPD development.

Main Methods:

  • Review of existing literature on BPD epidemiology, pathophysiology, and therapeutic interventions.
  • Analysis of factors contributing to lung injury, including altered lung development, birth resuscitation, and postnatal exposures.
  • Examination of inflammatory pathways and the role of corticosteroids in mitigating BPD.

Main Results:

  • BPD is a lung injury syndrome with clear epidemiological trends but lacks a precise definition for predicting mortality and long-term outcomes.
  • Lung injury leading to BPD likely initiates during altered prenatal development and is exacerbated by postnatal factors like oxygen, ventilation, and infection.
  • Recent trials demonstrate that early corticosteroid administration can reduce BPD incidence and severity, suggesting inflammation plays a key role.

Conclusions:

  • BPD is a complex disease resulting from the continuous interaction of altered lung development, injury, and repair processes.
  • Further research is needed to understand "adaptation" and "tolerance" responses that modulate lung injury and repair.
  • Addressing knowledge gaps is crucial for developing effective strategies to prevent and treat BPD in vulnerable infants.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
4.5K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
66.0K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.4K